Nursing care of patients receiving orthoclone OKT 3

Area of Science:

• Immunology
• Nephrology
• Transplantation

Background:

• Orthoclone OKT 3 (muromonab-CD3) is a murine monoclonal antibody targeting the T3 antigen on human T lymphocytes.
• It has demonstrated efficacy in managing acute cell-mediated renal allograft rejection.
• Therapy with OKT 3 is associated with significant, albeit temporary, adverse reactions.

Purpose of the Study:

• To identify common nursing diagnoses associated with Orthoclone OKT 3 (muromonab-CD3) therapy.
• To highlight the critical need for vigilant nursing care and patient monitoring during OKT 3 treatment.

Main Methods:

• Clinical observation and analysis of patient responses to Orthoclone OKT 3 (muromonab-CD3).
• Identification of prevalent adverse reactions and associated nursing care requirements.

Main Results:

• Common adverse reactions necessitate nursing diagnoses including altered respiratory function, hyperthermia, pain, fluid volume deficit, infection risk, and knowledge deficit.
• These side effects, while transient, can be severely disabling for patients undergoing treatment.

Conclusions:

• Effective management of acute renal allograft rejection with Orthoclone OKT 3 (muromonab-CD3) requires proactive nursing interventions.
• Diligent nursing care and continuous monitoring are essential to mitigate adverse effects and ensure patient safety during OKT 3 therapy.